Michele Boyd, CRNA - Medicare Certified Registered Nurse Anesthetist (crna) in Nashua, NH

Michele Boyd, CRNA is a medicare enrolled "Nurse Anesthetist, Certified Registered" in Nashua, New Hampshire. She graduated from nursing school in 2004 and has 20 years of diverse experience with area of expertise as Certified Registered Nurse Anesthetist (crna). She is a member of the group practice Amoskeag Anesthesia Pllc and her current practice location is 168 Kinsley St, Suite 4, Nashua, New Hampshire. You can reach out to her office (for appointments etc.) via phone at (603) 882-1501.

Michele Boyd is licensed to practice in New Hampshire (license number 043721-23) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1528168630.

Contact Information

Michele Boyd, CRNA
168 Kinsley St, Suite 4,
Nashua, NH 03060-3634
(603) 882-1501
(603) 882-9747



Provider's Profile

Full NameMichele Boyd
GenderFemale
SpecialityCertified Registered Nurse Anesthetist (crna)
Experience20 Years
Location168 Kinsley St, Nashua, New Hampshire
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Michele Boyd graduated from nursing school in 2004
  NPI Data:
  • NPI Number: 1528168630
  • Provider Enumeration Date: 09/25/2006
  • Last Update Date: 01/23/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 2668425349
  • Enrollment ID: I20050222000708

Medical Identifiers

Medical identifiers for Michele Boyd such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1528168630NPI-NPPES
30343699MedicaidNH
40Y008421NH01OtherNHANTHEM BLUE SHIELD

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
367500000XNurse Anesthetist, Certified Registered 04200154 (New Hampshire)Secondary
367500000XNurse Anesthetist, Certified Registered 043721-23 (New Hampshire)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Amoskeag Anesthesia Pllc175937598393

News Archive

Schizophrenics who fail to take their medicines are over one-and-a-half times as likely to be rehospitalised

Patients with schizophrenia who fail to take their medicines as prescribed are over one-and-a-half times as likely to be rehospitalised and use in-patient services as patients who stick to their medication regimen. Non-adherence predicted an excess annual cost per patient of £5000 for total service use.

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.

The Children's Hospital, Denver Health sign Affiliation Agreement to care for children of all ages

The Children's Hospital and Denver Health have signed an official Affiliation Agreement to leverage the substantial strengths of both institutions to provide outstanding programs in pediatric patient care, education, research and advocacy. Under the agreement, two of the largest pediatric health care providers in the region are able to provide improved access for patients, share best practices and more efficiently use resources.

Roche and WHO reinforce Tamiflu as primary H5N1 treatment

The World Health Organization (WHO) has reinforced that Tamiflu (oseltamivir) is the primary recommended antiviral of choice in managing patients infected with H5N1 in updated guidance published on the WHO website today.

Too much tea raises the risk of rheumatoid arthritis: Study

Rheumatoid arthritis (RA) a severely debilitating inflammatory disease of the joints is on the rise worldwide. It leads to severe pain, stiffness, swelling and loss of movement of joints like knees, wrist and even fingers. RA affects women more than men. RA occurs in people who develop a rogue immune system that attacks the tissue that lines the joint cavities called the synovium leading to degeneration of the joints and the symptoms of the disease. In 1995 36.4 per 100,000 women were diagnosed with RA whereas in 2005 the number rose to 54 per 100,000 women.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Michele Boyd allows following entities to bill medicare on her behalf.
Entity NameAmoskeag Anesthesia Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1104883511
PECOS PAC ID: 1759375983
Enrollment ID: O20040513001385

News Archive

Schizophrenics who fail to take their medicines are over one-and-a-half times as likely to be rehospitalised

Patients with schizophrenia who fail to take their medicines as prescribed are over one-and-a-half times as likely to be rehospitalised and use in-patient services as patients who stick to their medication regimen. Non-adherence predicted an excess annual cost per patient of £5000 for total service use.

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.

The Children's Hospital, Denver Health sign Affiliation Agreement to care for children of all ages

The Children's Hospital and Denver Health have signed an official Affiliation Agreement to leverage the substantial strengths of both institutions to provide outstanding programs in pediatric patient care, education, research and advocacy. Under the agreement, two of the largest pediatric health care providers in the region are able to provide improved access for patients, share best practices and more efficiently use resources.

Roche and WHO reinforce Tamiflu as primary H5N1 treatment

The World Health Organization (WHO) has reinforced that Tamiflu (oseltamivir) is the primary recommended antiviral of choice in managing patients infected with H5N1 in updated guidance published on the WHO website today.

Too much tea raises the risk of rheumatoid arthritis: Study

Rheumatoid arthritis (RA) a severely debilitating inflammatory disease of the joints is on the rise worldwide. It leads to severe pain, stiffness, swelling and loss of movement of joints like knees, wrist and even fingers. RA affects women more than men. RA occurs in people who develop a rogue immune system that attacks the tissue that lines the joint cavities called the synovium leading to degeneration of the joints and the symptoms of the disease. In 1995 36.4 per 100,000 women were diagnosed with RA whereas in 2005 the number rose to 54 per 100,000 women.

Read more Medical News

› Verified 7 days ago

Entity NameDartmouth-hitchcock Clinic
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548210198
PECOS PAC ID: 4183537509
Enrollment ID: O20040809000442

News Archive

Schizophrenics who fail to take their medicines are over one-and-a-half times as likely to be rehospitalised

Patients with schizophrenia who fail to take their medicines as prescribed are over one-and-a-half times as likely to be rehospitalised and use in-patient services as patients who stick to their medication regimen. Non-adherence predicted an excess annual cost per patient of £5000 for total service use.

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.

The Children's Hospital, Denver Health sign Affiliation Agreement to care for children of all ages

The Children's Hospital and Denver Health have signed an official Affiliation Agreement to leverage the substantial strengths of both institutions to provide outstanding programs in pediatric patient care, education, research and advocacy. Under the agreement, two of the largest pediatric health care providers in the region are able to provide improved access for patients, share best practices and more efficiently use resources.

Roche and WHO reinforce Tamiflu as primary H5N1 treatment

The World Health Organization (WHO) has reinforced that Tamiflu (oseltamivir) is the primary recommended antiviral of choice in managing patients infected with H5N1 in updated guidance published on the WHO website today.

Too much tea raises the risk of rheumatoid arthritis: Study

Rheumatoid arthritis (RA) a severely debilitating inflammatory disease of the joints is on the rise worldwide. It leads to severe pain, stiffness, swelling and loss of movement of joints like knees, wrist and even fingers. RA affects women more than men. RA occurs in people who develop a rogue immune system that attacks the tissue that lines the joint cavities called the synovium leading to degeneration of the joints and the symptoms of the disease. In 1995 36.4 per 100,000 women were diagnosed with RA whereas in 2005 the number rose to 54 per 100,000 women.

Read more Medical News

› Verified 7 days ago

Entity NameGranite State Anesthesiologists, Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1366658700
PECOS PAC ID: 1355394032
Enrollment ID: O20050222000661

News Archive

Schizophrenics who fail to take their medicines are over one-and-a-half times as likely to be rehospitalised

Patients with schizophrenia who fail to take their medicines as prescribed are over one-and-a-half times as likely to be rehospitalised and use in-patient services as patients who stick to their medication regimen. Non-adherence predicted an excess annual cost per patient of £5000 for total service use.

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.

The Children's Hospital, Denver Health sign Affiliation Agreement to care for children of all ages

The Children's Hospital and Denver Health have signed an official Affiliation Agreement to leverage the substantial strengths of both institutions to provide outstanding programs in pediatric patient care, education, research and advocacy. Under the agreement, two of the largest pediatric health care providers in the region are able to provide improved access for patients, share best practices and more efficiently use resources.

Roche and WHO reinforce Tamiflu as primary H5N1 treatment

The World Health Organization (WHO) has reinforced that Tamiflu (oseltamivir) is the primary recommended antiviral of choice in managing patients infected with H5N1 in updated guidance published on the WHO website today.

Too much tea raises the risk of rheumatoid arthritis: Study

Rheumatoid arthritis (RA) a severely debilitating inflammatory disease of the joints is on the rise worldwide. It leads to severe pain, stiffness, swelling and loss of movement of joints like knees, wrist and even fingers. RA affects women more than men. RA occurs in people who develop a rogue immune system that attacks the tissue that lines the joint cavities called the synovium leading to degeneration of the joints and the symptoms of the disease. In 1995 36.4 per 100,000 women were diagnosed with RA whereas in 2005 the number rose to 54 per 100,000 women.

Read more Medical News

› Verified 7 days ago

Entity NameNarragansett Bay Anesthesia Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1861445728
PECOS PAC ID: 5991774929
Enrollment ID: O20200506000292

News Archive

Schizophrenics who fail to take their medicines are over one-and-a-half times as likely to be rehospitalised

Patients with schizophrenia who fail to take their medicines as prescribed are over one-and-a-half times as likely to be rehospitalised and use in-patient services as patients who stick to their medication regimen. Non-adherence predicted an excess annual cost per patient of £5000 for total service use.

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.

The Children's Hospital, Denver Health sign Affiliation Agreement to care for children of all ages

The Children's Hospital and Denver Health have signed an official Affiliation Agreement to leverage the substantial strengths of both institutions to provide outstanding programs in pediatric patient care, education, research and advocacy. Under the agreement, two of the largest pediatric health care providers in the region are able to provide improved access for patients, share best practices and more efficiently use resources.

Roche and WHO reinforce Tamiflu as primary H5N1 treatment

The World Health Organization (WHO) has reinforced that Tamiflu (oseltamivir) is the primary recommended antiviral of choice in managing patients infected with H5N1 in updated guidance published on the WHO website today.

Too much tea raises the risk of rheumatoid arthritis: Study

Rheumatoid arthritis (RA) a severely debilitating inflammatory disease of the joints is on the rise worldwide. It leads to severe pain, stiffness, swelling and loss of movement of joints like knees, wrist and even fingers. RA affects women more than men. RA occurs in people who develop a rogue immune system that attacks the tissue that lines the joint cavities called the synovium leading to degeneration of the joints and the symptoms of the disease. In 1995 36.4 per 100,000 women were diagnosed with RA whereas in 2005 the number rose to 54 per 100,000 women.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michele Boyd is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Michele Boyd, CRNA
139 Joppa Rd,
Merrimack, NH 03054-3109

Ph: (603) 589-1885
Michele Boyd, CRNA
168 Kinsley St, Suite 4,
Nashua, NH 03060-3634

Ph: (603) 882-1501

News Archive

Schizophrenics who fail to take their medicines are over one-and-a-half times as likely to be rehospitalised

Patients with schizophrenia who fail to take their medicines as prescribed are over one-and-a-half times as likely to be rehospitalised and use in-patient services as patients who stick to their medication regimen. Non-adherence predicted an excess annual cost per patient of £5000 for total service use.

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that the Company has been granted two new patents, "Co-administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer" in Australia and "Selectively Depolymerized Galactomannan Polysaccharide" in the United States.

The Children's Hospital, Denver Health sign Affiliation Agreement to care for children of all ages

The Children's Hospital and Denver Health have signed an official Affiliation Agreement to leverage the substantial strengths of both institutions to provide outstanding programs in pediatric patient care, education, research and advocacy. Under the agreement, two of the largest pediatric health care providers in the region are able to provide improved access for patients, share best practices and more efficiently use resources.

Roche and WHO reinforce Tamiflu as primary H5N1 treatment

The World Health Organization (WHO) has reinforced that Tamiflu (oseltamivir) is the primary recommended antiviral of choice in managing patients infected with H5N1 in updated guidance published on the WHO website today.

Too much tea raises the risk of rheumatoid arthritis: Study

Rheumatoid arthritis (RA) a severely debilitating inflammatory disease of the joints is on the rise worldwide. It leads to severe pain, stiffness, swelling and loss of movement of joints like knees, wrist and even fingers. RA affects women more than men. RA occurs in people who develop a rogue immune system that attacks the tissue that lines the joint cavities called the synovium leading to degeneration of the joints and the symptoms of the disease. In 1995 36.4 per 100,000 women were diagnosed with RA whereas in 2005 the number rose to 54 per 100,000 women.

Read more News

› Verified 7 days ago


Nurse Anesthetist, Certified Registered Nurses in Nashua, NH

Durrell Smith, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 5 Coliseum Ave, Nashua, NH 03063
Phone: 603-882-9800    Fax: 603-882-0556
Karen Grace Wiginton, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 8 Prospect St, Nashua, NH 03060
Phone: 603-577-2000    
Paul G Krum,
Nurse Anesthetist - CR
Medicare: Medicare Enrolled
Practice Location: 8 Prospect St, Nashua, NH 03060
Phone: 603-577-2000    
Elizabeth P Salser, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 8 Prospect St, Nashua, NH 03060
Phone: 804-523-0908    
Mrs. Jane M Gill, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 8 Prospect St, Nashua, NH 03060
Phone: 603-521-5867    
Maggie Blank, CRNA
Nurse Anesthetist - CR
Medicare: Accepting Medicare Assignments
Practice Location: 168 Kinsley St, Suite 4, Nashua, NH 03060
Phone: 603-882-1501    Fax: 603-882-9747

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.